Roaming through your body is a group of specialized immune cells which act stealthily and authoritatively. They "ask" other body cells to show them identification ("papers please!"). If they fail to provide adequate ID those cells are killed on the spot. No questions asked. Scientists are now recruiting these cells to help in the fight against cancer.
Providing healthcare by region increases experience and improves outcomes. But what happens when you have a complication ... and your doctors and regional care is a few hours away?
Should we turn our nose up at using a dog's keen sense of smell as a cancer screening tool? Or to help identify relevant biomarkers that scientists should be isolating for diagnostic purposes?
Brand names are meant to communicate trust that products are of a certain high quality. But healthcare is not a product in that way, and once again hospital's branded with a flagship's name often produce results that are not as good as the flagship itself. Let the patient beware.
Though recent and alarming headlines are touting a global superbug, it can be hard to discern fact from fiction. Should we be worried? Let's take a look and find out.
Given therapeutics in the cancer category dominate the list is not so surprising, given the hefty price tag they yield. Where there is a great return there tends to be a great investment.
Expectant parents are bombarded with costly propositions. Diverting attention to all the "what ifs" can be distracting, as compared to "what actually is." Storing their infant's cord blood can be preoccupying. But is it worth it?
Of course, not all causes and manners of death are within our control. Nor should we be so preoccupied with them that we avoid living. But the National Safety Council's annual report proves to be an interesting read, given a 5.3% increase in preventable-injury-related deaths.
Despite having yet to save a mouse, last week a company created headlines when it said that it would cure all cancers -- in a year. Let's clarify what promise actually exists in the field, and what hurdles still need to be overcome.
Despite having yet to save the life of a mouse, an Israeli company is making grandiose pronouncements. However, if you look beyond the hype the medical approach is actually pretty interesting.
With cancer death rates declining 27% over a quarter century, there's much cause for celebrating. But now, complacency is not an option.